Biolase (NSDQ:BIOL) said late last month that it reached a settlement deal with CAO Group to end a patent infringement suit the companies were engaged in over laser technologies, according to an SEC filing. Irvine, Calif.-based Biolase said that CAO agreed to dismiss with prejudice lawsuits it filed against Biolase in April 2012 and again in January 2018 […]
CAO Group
CAO Group files laser diode patent infringement suits against Biolase
CAO Group said this week it filed patent infringement lawsuits against Biolase (NSDQ:BIOL) over diode laser patents, revisiting infringement suits that began in 2012. The West Jordan, Utah-based company said it filed in the United States District Court for the State of Utah and in the United States District Court for the Central District of California against Biolase. In Utah, the company said […]
Biolase gets FDA nod for new tissue laser
Biolase (NSDQ:BIOL) won 510(k) clearance from the FDA for its WaterLase iPlus, a laser used for soft-tissue orthopedic procedures.
The clearance opens up a $2.6 billion market opportunity for the WaterLase device, according to a company statement.